Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Frank Mottola

Svp, Chief Tech. Ops. Officer at Supernus Pharmaceuticals, Inc. (SUPN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 10SEC SUPNSupernus Pharmaceuticals, Inc. Sell 1,62318,440 held (−8%) $53.65 $87K -29.4%
Dec 22SEC SUPNSupernus Pharmaceuticals, Inc. Sell Plan 5,00015,496 held (−24%) $50.22 $251K -24.6%
Dec 22SEC SUPNSupernus Pharmaceuticals, Inc. Sell Plan 15,00015,496 held (−49%) $50.47 $757K -24.9%
  • Sell

    Svp, Chief Tech. Ops. Officer Frank Mottola sold $251K of SUPN at $50.22 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp, Chief Tech. Ops. Officer Frank Mottola sold $757K of SUPN at $50.47 — cuts the stake by 49%; pre-scheduled 10b5-1 plan sale.